Twitter
Google plus
Facebook
Vimeo
Pinterest

Fluid Edge Themes

MILAD RIAZIFAR, PH.D

DIRECTOR OF RESEARCH AND DEVELOPMENT

Dr. Riazifar has worked on stem cells over a decade and on exosomes a subclass of stem cell derived extracellular vesicles since 2012. During his Ph.D studies at the Stem Cell Research Center at the University of California Irvine, he pioneered a cell-free exosome-based approach to treat Multiple Sclerosis. At City of Hope, he was part of a clinical translation team initiating the world’s first clinical trial using stem cell exosomes for the treatment of type I diabetes.

Dr. Riazifar has extensive experience in manufacturing and characterizing pharmaceutical-grade exosomes, and has developed numerous in vitro potency assays, and is overseeing IND-enabling preclinical studies. He has published numerous high-impact articles on stem cells and stem cell-derived exosomes, and has consulted for regenerative medicine companies. Dr. Riazifar received his Ph.D in pharmaceutical sciences from UC Irvine.